Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 126476 dokumen yang sesuai dengan query
cover
Fahrani Imanina Putri Nurtyas
"Pasien sindrom koroner akut (SKA) dengan penyakit ginjal kronik (PGK) diketahui memiliki risiko mortalitas lebih tinggi dibandingkan dengan pasien SKA tanpa disertai PGK. Setiap tahunnya, dilaporkan 9% kematian akibat penyakit jantung koroner (PJK) yang disertai PGK, yaitu hampir 10 – 20 kali lebih tinggi dibanding populasi umum. Pada pasien SKA dengan PGK terjadi proses inflamasi kronik yang memainkan peranan penting dalam perubahan morfologi dan fungsional sel endotel yang mengakibatkan akselerasi proses aterosklerosis yang berkaitan dengan keparahan koroner pasien SKA dan berujung meningkatkan kejadian major adverse cardiac event (MACE). Penelitian ini bertujuan untuk mengetahui peran rasio neutrofil limfosit (RNL) sebagai prediktor MACE dan korelasinya dengan derajat keparahan koroner pada pasien SKA dengan PGK. Digunakan 2 desain pada penelitian ini, yaitu studi nested case control dengan 31 subjek yang mengalami MACE sebagai kelompok kasus dan 28 subjek yang tidak mengalami MACE sebagai kelompok kontrol dari total 59 pasien SKA dengan PGK, serta studi korelatif dengan pendekatan potong lintang. Pada penelitian ini didapatkan area under curve (AUC) sebesar 60,8% dengan nilai titik potong RNL terhadap kejadian MACE adalah 3,62 dengan sensitivitas 74,2% dan spesifisitas 42,9%. Tidak terdapat perbedaan dan hubungan yang bermakna antara nilai RNL dengan kejadian MACE (p>0,05; OR=2,16 [95%CI=0,63 – 7,51]) dan tidak terdapat korelasi antara nilai RNL dengan derajat keparahan koroner yang dinilai menggunakan skor Gensini (r=0,10; p=0,474).

Acute coronary syndrome (ACS) patients with chronic kidney disease (CKD) are known to have a higher risk of mortality compared to ACS patients without CKD. Every year, 9% of deaths due to coronary heart disease (CHD) accompanied by CKD reported, which is almost 10 – 20 times higher than the general population. In ACS patients with CKD, chronic inflammation play an important role in morphological and functional changes in endothelial cells that resulted in atherosclerosis acceleration associated with coronary severity in SKA patients, thus lead the increase in major adverse cardiac events (MACE). This study aims to determine the role of neutrophil lymphocyte ratio (NLR) as a predictor of MACE and its correlation with the degree of coronary severity in ACS patients with CKD. Two designs were used in this study, first using nested case control study with 31 subjects who experienced MACE as a case group and 28 subjects who did not experience MACE as a control group of a total of 59 ACS patients with CKD. Second using correlative study with a cross-sectional approach. Area under curve (AUC) of 60.8% was obtained with an NLR cutoff value for MACE is 3.62 with 74.2% sensitivity and 42.9% specificity. There is no significant difference and relationship between NLR and MACE (p>0.05; OR= 2.16 [95%CI=0.63 – 7.51]), also no correlation between NLR and coronary severity degree assessed using Gensini score (r = 0.10; p = 0.474)."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2020
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Darmawan
"Rasio Netrofil-Limfosit (RNL) adalah pemeriksaan laboratorium murah dan mudah didapatkan dimanapun, dan saat ini berkembang menjadi penanda luaran pada berbagai kondisi, termasuk pada Sindrom Koroner Akut (SKA). RNL menggabungkan dua jalur inflamasi berbeda (netrofil dan limfosit) untuk memprediksi luarannya, dan beberapa studi telah menunjukkan manfaatnya dalam memprediksi Major Adverse Cardiac Events (MACE). Penelitian ini bertujuan untuk membuktikan manfaat RNL dalam stratifikasi risiko SKA pada populasi Indonesia, dan menentukan nilai titik potong RNL untuk peningkatan risiko MACE.
Metode: 380 rekam medis pasien SKA dari Januari 2012-Agustus 2015 diikutkan dalam studi ini. Karakteristik, faktor risiko kardiovaskuler, dan hasil pemeriksaan laboratorium subjek dikumpulkan dan diikuti secara retrospektif untuk menilai kemunculan MACE (aritmia, infark ulang, in-stent restenosis, gagal jantung akut, syok kardiogenik, kematian) selama perawatan. Nilai RNL didapatkan dari pembagian hitung netrofil dan limfosit absolut. Analisis statistik untuk menentukan nilai titik potong RNL dan penyesuaian untuk faktor perancu dilakukan untuk memvalidasi hasil.
Hasil: Subjek mayoritas merupakan laki-laki, dengan rerata usia 57,92 tahun. Hipertensi dan merokok merupakan faktor risiko yang paling sering ditemukan. Rerata RNL subjek adalah 4,72, dan MACE ditemukan pada 73 kasus (19,2%). Setelah analisis ROC, didapatkan nilai titik potong sebesar 3.55 (sensitivitas 72,6%, spesitifitas 60,6%, AUC 0.702). Ditemukan bahwa terdapat peningkatan insidens MACE pada kelompok RNL>3.55 (30.47% vs 9.71% pada ≤3.55, p<0.001). Setelah penyesuaian untuk faktor perancu, RNL>3.55 tetap signifikan dalam memprediksi MACE (p=0.02, adujsted OR 2,626 (IK95% 1,401-4,922)).
Kesimpulan: RNL>3.55 adalah prediktor independen untuk kejadian MACE.

Background: Neutrophil-Lymphocyte Ratio (NLR) is a low-cost, readily available laboratory examination in various places, and is currently emerging as a prognostic marker for various conditions, including Acute Coronary Syndrome (ACS). NLR, which combines two different inflammatory pathways (neutrophil and lymphocyte), have been shown by several studies to be useful in predicting Major Adverse Cardiac Events (MACE). This study aims to prove NLR’s use in ACS risk stratification in Indonesians and determine a cutoff level for MACE risk increase.
Methods: 380 ACS patients’ medical records from January 2012 to August 2015 were included in this study. Subjects’ characteristics, cardiovascular risk factors and laboratory findings were collected, and retrospectively followed to evaluate for MACE (arrhythmia, reinfarction, in-stent restenosis, acute heart failure, cardiogenic shock, death) during hospitalization. NLR value was calculated from neutrophil and lymphocyte counts division. Statistical analysis to determine NLR cutoff point for MACE risks, and adjustment for confounding factors were done for results validation.
Results: Subjects were predominantly male, with average age of 57.92 years old. Hypertension and smoking were the most frequent risk factors found. Average NLR was 4.72, and MACE was found in 73 cases (19.2%). After ROC analysis, a cutoff of 3.55 was determined to be satisfactory (sensitivity 72.6%, spesitivity 60.6%, AUC 0.702). It was found that there is a significant increase in MACE incidence in NLR>3.55 (30.47% vs 9.71% in ≤3.55, p<0.001). After adjusting for confounding factors, NLR>3.55 was still significant in predicting MACE (p=0.02, adujsted OR 2,626 (CI95% 1,401-4,922)).
Conclusion: NLR>3.55 is an independent predictor of in-hospital MACE.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2016
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Agoes Kooshartoro
"Latar Belakang : Indonesia memiliki angka kematian karena penyakit kardiovaskular yang semakin meningkat, dengan angka kematian diperkirakan sebanyak 17,3 juta kematian. Mengingat tingkat mortalitas yang sangat tinggi pada pasien dengan sindrom koroner akut SKA, maka diperlukan sebuah prediktor Major Adverse Cardiac Event MACE yang objektif dan terukur untuk manajemen pasien SKA dalam jangka panjang. Pada SKA dapat ditemukan heterogenitas repolarisasi ventrikel yang dapat dilihat pada elektrokardiografi EKG sebagai QTmax-QTmin, atau dapat disebut sebagai QTD.QTD disinyalir dapat dijadikan penanda untuk risiko MACE pada pasien SKA.
Tujuan : Mengetahui peran dispersi QT dan QTcD sebagai prediktor MACE pada pasien sindrom koroner akut SKA.
Metode : Penelitian ini merupakan studi kohort retrospektif pada 230 rekam medis pasien SKA yang dirawat di ICCU RSCM dalam rentang waktu Januari 2016 hingga November 2017. EKG standar 12 sadapan saat serangan dianalisis dan dilakukan pengukuran interval QTmax dan QTmin yang kemudian dihitung QTd. Selanjutnya dikoreksi dengan frekuensi nadi menggunakan rumus Bazett QTcD.
Hasil : Pemanjangan QTD lebih dari 100mdet dapat menjadi prediktor MACE pada pasien dengan SKA OR 1,25 IK95 0,17 ndash; 2,71 . Setelah dikoreksi dengan frekuensi nadi menggunakan rumus Bazett, pemanjangan QTcD juga dapat menjadi prediktor MACE pada pasien SKA 1,89 IK95 0,05 ndash; 67,37.
Kesimpulan : Pemanjangan QTD lebih dari 100mdet atau QTcD lebih dari 12,72mdet dapat menjadi prediktor MACE.

Background: In Indonesia, the number of death due to cardiovascular disease is rapidly rising and it was approximated to have resulted in 17,3 million deaths. Due to this steadily increasing cases, it is necessary to find a predictor for Major Adverse Cardiac Event MACE that is objective and standardized for long term care of patients with acute coronary syndrome ACS. In ACS, one of the underlying mechanisms is the presence of heterogeneity in ventricle repolarization that is seen on ECG machine as QTmax ndash QTmin, or what is identified as QTD. QTD is hypothesized to have role as marker in patients with MACE in ACS.
Aim: Identify the role of QTD and QTcD as MACE predictor in patients with acute coronary syndrome.
Methods: This study is a retrospective cohort with the subject of 230 ACS patients that was hospitalised on RSCM ICCU among January 2016 to November 2017. Data was taken from medical record and 12 lead ECG during attack were taken and analysed manually to calculate QTmax and QTmin and substraction of both into QTD. Followed by correction using the heart rate with Bazett formula QTcD.
Result: QTD prolongation of more than 100ms in patients with ACS may lead to MACE OR 1,25 IK95 0,17 ndash 2,71 . Following correction with Bazett formula, QTcD prolongation is also predictor 1,89 IK95 0,05 ndash 67,37.
Conclusion: QTD prolongation of more than 100ms or QTcD of more than 12.72ms might lead to MACE
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
T59198
UI - Tesis Membership  Universitas Indonesia Library
cover
Anastasia Asylia Dinakrisma
"Latar Belakang: Kematian kardiak dan reinfark merupakan MACE yang sering terjadi pada pasien SKA. Gelombang fragmented QRS fQRS merupakan penanda iskemia atau jejas miokardium dini pada pasien sindrom koroner akut SKA. Peran fQRS terhadap MACE 30 hari perlu diteliti lebih lanjut pada pasien SKA.
Tujuan: Mengetahui peran fQRS sebagai prediktor MACE berupa reinfark dan kematian kardiak pada pasien SKA di ICCU selama 30 hari.
Metode: Studi dengan desain kohort retrospektif untuk meneliti peran gelombang fragmented QRS sebagai prediktor MACE selama 30 hari pasien SKA, dengan menggunakan data rekam medis pasien SKA yang menjalani perawatan di ICCU RSCM pada bulan Juli 2015 - Oktober 2017. Analisis bivariat dan multivariat dengan logistik regresi dilakukan untuk menghitung crude risk ratio RR dan adjusted RR terjadinya MACE dalam 30 hari antara kelompok fQRS terhadap kelompok non-fQRS dengan menggunakan SPSS.
Hasil: Dalam 2 tahun, didapatkan jumlah subyek yang memenuhi kriteria inklusi dan eksklusi sebanyak 353 orang. Fragmented QRS didapatkan pada 60,9 subyek, dengan lokasi terbanyak di inferior 48,8 dan rerata onset 34 jam. Proporsi kejadian MACE 30 hari lebih tinggi pada grup fQRS vs non fQRS 15,8 vs 5,8. Pada analisis bivariat didapatkan fQRS meningkatkan probabilitas terjadinya MACE selama 30 hari pada pasien SKA, dengan risiko relatif RR sebesar 2,72 IK 95 1,3 -5,71. Sedangkan pada analisis multivariat, didapatkan adjusted RR 2,79 IK 95 1,29 - 4,43, setelah memperhitungkan 6 faktor perancu, yakni skor GRACE risiko sedang-berat, eGFR kurang dari 60 ml/menit, LVEF kurang dari 40, riwayat diabetes melitus, usia lebih dari 45 tahun dan hipertensi. Laju eGFR merupakan faktor perancu yang memberikan perubahan paling besar, yakni 12,4.
Kesimpulan: Proporsi fQRS pada SKA selama perawatan di ICCU RSCM sebesar 60,9. Fragmented QRS yang muncul pada fase akut pada pasien SKA yang dirawat di ICCU merupakan prediktor independen terjadinya MACE dalam 30 hari dan meningkatkan probabiltas terjadinya MACE 30 hari berupa kematian kardiak dan reinfark pada pasien SKA.

Background: Cardiac death and reinfarction are most common major adverse cardiac events in acute coronay syndrome. Fragmented QRS fQRS in 12 leads ECG is associated with myocardial injury and ischaemia in coronary artery disease. The role of fQRS as predictor of 30 days MACE cardiac death and reinfarction needs to be evaluated in acute coronary syndrome patients in Indonesia.
Objectives: To identify proportion and role of fQRS as a predictor 30 days MACE in acute coronary syndrome patients.
Methods: A cohort retrospective study was conducted by using secondary data acute coronary syndrome patients in Intensive Cardiac Care Unit Cipto Mangunkusumo Hospital from July 2015 ndash October 2017. Analysis was done by using SPSS statistic for univariate, bivariate and multivariate logistic regression to obtain crude risk ratio and adjusted risk ratio of probability 30 days MACE patient with fQRS.
Result: Three hundred and fifty three subjects during 2 years were included in this study. Fragmented QRS was found in 60,9 subjects, more frequent in inferior leads 48,8, with mean onset 34 hours. Major adverse cardiac events were higher in fQRS vs non fQRS group 15,8 vs 5,8. Bivariate analysis showed higher probability of 30 days MACE in ACS patient RR 2,72, 95 CI 1,3 5,71. Multivariate analysis were done by using logistic regression with GRACE score moderate and high risk, low eGFR 60 ml min, low LVEF 40, diabetes melitus, age more than 45 years and hypertension as confounding factors, revealed adjusted RR was 2,79 95 CI 1,29 ndash 4,43. Low eGFR was a potential confounder in this study.
Conclusion: The fQRS proportion in ACS patients during ICCU admission was 60,9. Acute and persistent fQRS developed in ACS during hospitalization was an independent predictor of 30 days MACE cardiac death and reinfarction.Keywords fQRS, acute coronary syndrome, Major adverse cardiac event.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Vincea Eko
"Sindrom koroner akut (SKA) merupakan masalah utama penyakit jantung yang merupakan penyebab kematian tertinggi setelah stroke di Indonesia. SKA dapat dinilai keparahannya melalui skor Gensini dan prognosisnya melalui kejadian Major Adverse Cardiac Event (MACE). High Sensitive Troponin T (hsTroponin T) adalah biomarker yang direkomendasikan beberapa badan internasional dalam mendiagnosis infark miokard. Pada pasien SKA yang disertai penyakit ginjal kronik (PGK) akan mempengaruhi hasil pemeriksaan hsTroponin T. Hal ini disebabkan oleh kadar ureum darah yang tinggi bersifat toksik dan kondisi PGK menurunkan fungsi ginjal sehingga mempengaruhi kadar hsTroponin T. Penelitian ini bertujuan mengetahui hubungan hstroponin T dan ureum dengan skor Gensini, MACE jangka pendek pada pasien SKA yang disertai PGK di RSUPN dr. Cipto Mangunkusumo. Metode penelitian adalah potong lintang dilakukan pada bulan Januari-Oktober 2018. Subjek penelitian meliputi seluruh pasien yang mengikuti penelitian terdahulu “ Pengaruh Beta 2- Mikroglobulin dan Fibroblast Growth Factor 23 terhadap Keparahan Koroner dan Major Adverse Cardiac Event pada Pasien Sindrom Koroner Akut dengan Penyakit Ginjal Kronik”. Kadar hsTroponin T dan ureum subjek SKA dengan PGK dihubungkan dengan skor Gensini dan kejadian MACE jangka pendek. Terdapat 80 subjek SKA dengan PGK, terdiri dari 63 subjek STEMI -NSTEMI dengan peningkatan hsTroponin T dan 17 subjek UAP. Terdapat 34 subjek mengalami MACE diantaranya ada 11 subjek yang meninggal. Tidak terdapat korelasi kadar hsTroponin T dengan skor Gensini, r = 0,095, p=0,401 dan juga ureum dengan skor Gensini, r = 0,107, p = 0,343. Peningkatan kadar hsTroponin T memberikan peningkatan Odds Ratio (OR) sebesar 1,59 dan ureum OR 3,14 dengan p<0,05 terhadap kejadian MACE jangka pendek. Titik potong hsTroponin T terhadap kejadian MACE jangka pendek sebesar 150,5ng/L dengan sensitivitas 53,5%, spesifisitas 55,3%, nilai prediksi positif (NPP) 48%, nilai prediksi negatif (NPN) 63,33%. Titik potong ureum terhadap kejadian MACE jangka pendek 47,45mg/dL dengan sensitivitas 52,9%, spesifisitas 47,8%, NPP 63,63%, NPN 63,79%. Berdasarkan hasil tersebut peningkatan kadar hsTroponin T diatas 150,5ng/L dan ureum47,45mg/dL berperan dalam meningkatkan risiko kejadian terjadinya MACE jangka pendek dengan OR 1,59 dan 3,14 pada pasien SKA dengan PGK. Gambaran kadar hsTroponin T bervariasi pada setiap stadium PGK tetapi ada kecenderungan peningkatan kadar seiring dengan peningkatan stadium PGK, untuk itu diperlukan penelitian lebih lanjut untuk mendapatkan gambaran kadar hsTroponin T yang lebih jelas.

Acute Coronary Syndrome(ACS) is the main problem in heart disease which is the highest mortality after stroke in Indonesia. ACS can be assess the severity degree by Gensini scoring and its prognosis by Major Adverse Cardiac Event (MACE). High sensitive Troponin T (hsTroponin T) is biomarker that recomended by several international associations in diagnosing miocard infarct. Level of hs Troponin T can be affected in patients with ACS and chronic kidney disease (CKD), because lower filtration in CKD and high level ureum has toxic effect.This research aimed in knowing the relation of hsTroponin T and ureum with Gensini score, short term MACE, in ACS and CKD in RSUPN dr. Cipto Mangunkusumo. Methods using cross sectional in January-October 2018. All patients in elder research “ Pengaruh Beta 2- Mikroglobulin dan Fibroblast Growth Factor 23 terhadap Keparahan Koroner dan Major Adverse Cardiac Event pada Pasien Sindrom Koroner Akut dengan Penyakit Ginjal Kronik”, are included in this research, and then search for the correlation between hsTroponin T, ureum and Gensini score, short term MACE. There are 80 subjects ACS with CKD, 63 subjects with STEMI -NSTEMI (ST Elevation Miocard Infarct-Non ST Elevation Miocard Infarct) and elevated level of hs-troponin T, 17 subjects UAP (Unstable Angina Pectoris), 34 subjects MACE and 11 subjects within were died. There is no correlation between hsTroponin T and Gensini score is not , r=0,095 with p=0,401. There is no correlation between ureum and Gensini score r= 0,107 with p=0,343. Level of hsTroponin T and ureum has odds ratio OR= 1,59 and 3,14, p<0,05 towards short term MACE. The cut off for hsTroponin T towards short term MACE is 150,5ng/L with sensitivity 53,5%, specificity 55,3%, positive predictive value (PPV) 48%, negative predictive value (NPV) 63,33%. The cut off for ureum towards short term MACE is 47,45mg/dL with sensitivity 52,9%, specificity 47,8%, PPV 63,63%,NPV 63,79%. The descriptions of hsTroponin T level are various in every stage of CKD. According to that results, ascending level in hsTroponin T with cut off 150,5ng/L and ureum 47,45mg/dL has an impact in short term MACE (OR hsTroponin T=1,59 and ureum=3,14) in patients with ACS and CKD. The descriptions of level hsTroponin T are variety, but have tendency to escalate level hsTroponin T in every stage of CKD and need advance research to have clear descriptions."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2021
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Vera Abdullah
"ABSTRAK
Latar belakang Major adverse cardiovascular events (MACE) masih menjadi target yang dicegah dalam tata laksana sindroma koroner akut (SKA). Rasio netrofil-limfosit (RNL) terkait dengan dampak atau prognosis pada pasien dengan penyakit ini. Kondisi psikologis berperan sebelum, selama dan setelah infark. Psikoterapi suportif singkat (PSS) ditujukan untuk membangun kepercayaan diri, mengurangi cemas dan memperbaiki mekanisme koping terhadap penyakit ini.
Tujuan Penelitian ini bertujuan membandingkan pengaruh PSS terhadap MACE, RNL dan gejala psikis pada pasien SKA yang dirawat di Intensive Cardiac Care Unit (ICCU).
Metode Penelitian ini merupakan uji klinis random tidak tersamar ganda untuk membandingkan kelompok yang mendapat intervensi PSS dengan kontrol pada pasien SKA yang dirawat di ICCU RSUPN Cipto Mangunkusumo mulai 18 April hingga 30 Juli 2019 terhadap MACE, RNL dan gejala psikis. Intervensi PSS berlangsung 5 sesi selama rawatan di ICCU, kelompok PSS dan kontrol akan difollow-up pada saat sebelum pulang rawatan terhadap MACE (fatal aritmia, infark miokard rekuren, syok kardiogenik dan kematian), RNL dan gejala psikis yang diukur menggunakan inventori Hospital Anxiety Depression Scale (HADS). Data dianalisis menggunakan uji Chi square dan t tidak berpasangan untuk distribusi normal dan uji Fisher dan Mann-Whitney untuk yang tidak terdistribusi normal.
Hasil Hasil menunjukkan kelompok PSS terdapat 32 pasien, dan kontrol sejumlah 35 pasien. Median usia sebesar 55 (32-86) tahun. Proporsi lelaki sebesar 74,6%. Rerata lama rawatan ICCU yaitu 5 (2-13) hari. Tidak ada kejadian MACE, namun insiden major adverse event lain (stroke) 3,13% pada PSS dan 5,71% pada kontrol. Rerata RNL kelompok PSS sebesar 3,35(2,26) dan kontrol 3,63(1,79), p 0,346 (95% KI -1,27-0,71). Delta rerata RNL 1,49, p 0,098 (95% KI -0,69 - 3,67); tanpa CHF 3,87(5,48), 0,33(2,54) pada kontrol, p 0,007 d 0,79; tanpa CAD 3,88(4,55), 0,84(2,51) pada kontrol, p 0,014, d 0,77. Rerata skor HAD-Ansietas kelompok PSS sebesar 4,63(3,52) dan kontrol 4,31(2,62), p 0,874 (95% KI -1,19 - 1,82). Delta rerata skor HAD-Ansietas sebesar -0,01, p 0,988 (95% KI -1,74-1,71). Rerata skor HAD-Depresi kelompok PSS sebesar 4,91 (2,63) dan kontrol 4,37 (3,05), p 0,447 (95% KI -0,86 - 1,93). Delta rerata skor HAD-Depresi sebesar 1,62, p 0,149 (95% KI -0,17 -3,41); dengan CHF 1,73(3,58), -1,27(2,8) pada kontrol, p 0,041, d 0,86; dengan CAD 2,08(3,4), -0,8(3,3) pada kontrol, p 0,035, d 0,80.

ABSTRACT
Background Major adverse cardiovascular events (MACE) is still the preventive target in management acute coronary syndrome (ACS). Neutrophil-lymphocyte ratio (NLR) is regarded to the impact or prognosis in this patients. Psychological conditions play a role before, during and after infarction. Brief supportive psychotherapy (BSP) is stressed in terms of building confidence, reduce anxiety and improve coping mechanisms of this illness.
Aim The present study aims to compare influence of BSP on MACE, NLR, and psychological symptom in ACS patients to control one in ICCU.
Method The study is a double opened clinical randomized study which was compared with controls before and after intervention to observe the influence of BSP on the patients with ACS who were treated in ICCU of RSUPN Cipto Mangunkusumo - Jakarta in April, 18th to July, 30th 2019 on MACE, NLR and psychological symptom. The BSP intervention was about 5 sessions as long as inpatient in ICCU, the BSP group and the control ones would be followed by the end of the day in ICCU for the MACE (fatal arrhythmias, recurrent myocardial infarction, cardiogenic shock, and death), NLR, and psychological symptom which it was measured with hospital anxiety depression scale (HADS) inventory. Data were analyzed with Chi square and independent t-test for normally distributed data and Fisher and Mann-Whitney test for abnormally ones.
Results The study results showed 32 patients in brief supportive psychotherapy group and 35 patients in control one. The median age was 55(32 - 86) years old. The male proportion was 74,6%. The median length of stay in ICCU was 5(2-13) days. There was no MACE, but incident of other major adverse event (stroke) 3,13% in BSP and 5,71% in control. The mean NLR was 3,35(2,26) in BSP group and 3,63(1,79) in control one, p 0,346 (95% CI -1,27 - 0,71). The mean delta of NLR was 1,49, p 0,098 (95% CI -0,69 - 3,67); without CHF 3,87(5,48), 0,33(2,54) in control group, p 0,007 d 0,79; without CAD 3,88(4,55), 0,84(2,51) in control one, p 0,014, d 0,77. The mean of HAD-Anxiety score was 4,63(3,52) in BSP group and 4,31(2,62) in control one, p 0,874 (95% CI -1,19 -1,82). The mean delta of HAD-Anxiety score was -0,01, p 0,988 (95% CI -1,74 - 1,71). The mean of HAD-Depression score was 4,91(2,63) in BSP group and 4,37(3,05) in control one, p 0,447 (95% CI -0,86 - 1,93). The mean delta of HAD-Depression score was 1,62, p 0,149 (95% CI -0,17 - 3,41); with CHF 1,73(3,58), -1,27(2,8) in control group, p 0,041, d 0,86; with CAD 2,08(3,4), -0,8(3,3) in control one, p 0,035, d 0,80.
Conclusions There was no MACE, but stroke incident lower in BSP than control one. There was influence of BSP on NLR in ACS patients without CHF or CAD, and psychological symptom in ACS ones with CHF or CAD."
Fakultas Kedokteran Universitas Indonesia, 2020
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Bhanu
"ABSTRAK
Latar Belakang: Kematian pada Penyakit Jantung Koroner (PJK) terutama akibat
tindakan revaskularisasi yang tertunda atau lesi koroner kompleks yang biasanya
lebih buruk pada populasi pasien PGK. Skor Modified ACEF merupakan sebuah
perangkat yang memiliki peran penting dalam prognosis mortalitas PJK. Skor
mACEF belum pernah digunakan untuk mengevaluasi kompleksitas lesi koroner.
Informasi tersebut berguna dalam menentukan prioritas tindakan angiografi
koroner.
Tujuan: Mendapatkan nilai diagnostik dan titik potong skor mACEF sebagai
prediktor kompleksitas lesi koroner pada pasien PGK stadium 3 dan 4 yang
mengalami sindrom koroner akut (SKA).
Metode: Penelitian ini merupakan uji diagnostik secara retrospektif terhadap 179
subjek PGK stadium 3 dan 4 yang mengalami SKA yang dirawat di ICCU RSCM
tahun 2012 hingga 2014. Analisis titik potong skor mACEF dilakukan dengan
menggunakan Receiver Operating Characteristic (ROC) curves dengan interval
kepercayaan (IK) sebesar 95%. Akurasi diagnostik skor mACEF dinilai dengan
cara menghitung sensitivitas, spesifisitas, RKP, dan RKN.
Hasil: Titik potong skor mACEF yang optimal adalah 2,288 dengan sensitivitas
90,9%, spesifisitas 63,7%, RKP 2,5, RKN 0,14 dan prevalens 55,3%.
Kesimpulan: Titik potong yang optimal skor mACEF pada populasi pasien PGK
stadium 3 dan 4 yang mengalami SKA adalah 2,288. Akurasi diagnostik skor mACEF dinilai baik.ABSTRACT
Background: Cardiovascular disease is one of the main causes of death mainly
due to delayed revascularization or complex coronary lesions which are usually
worse in CKD patients. Modified ACEF (mACEF) score is well established in
determining cardiovascular mortality of patients undergoing revascularization
therapy and has never been used to evaluate the complexity of coronary lesions
before. mACEF score?s potential as a diagnostic tool needs to be evaluated to help
stratify patients eligible for coronary angiography.
Aim: To evaluate mACEF score?s diagnostic value and cut-off point as a
predictor of coronary lesion complexity in patients with CKD stages 3 and 4 with
ACS.
Methods: This study is a diagnostic test conducted retrospectively involving 179
subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012
to 2014. Cut-off analysis was performed using ROC curve with confidence
intervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed to
generate sensitivity, specificity, LR+, and LR-.
Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of
90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%.
Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainly
due to delayed revascularization or complex coronary lesions which are usually
worse in CKD patients. Modified ACEF (mACEF) score is well established in
determining cardiovascular mortality of patients undergoing revascularization
therapy and has never been used to evaluate the complexity of coronary lesions
before. mACEF score?s potential as a diagnostic tool needs to be evaluated to help
stratify patients eligible for coronary angiography.
Aim: To evaluate mACEF score?s diagnostic value and cut-off point as a
predictor of coronary lesion complexity in patients with CKD stages 3 and 4 with
ACS.
Methods: This study is a diagnostic test conducted retrospectively involving 179
subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012
to 2014. Cut-off analysis was performed using ROC curve with confidence
intervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed to
generate sensitivity, specificity, LR+, and LR-.
Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of
90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%.
Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainly
due to delayed revascularization or complex coronary lesions which are usually
worse in CKD patients. Modified ACEF (mACEF) score is well established in
determining cardiovascular mortality of patients undergoing revascularization
therapy and has never been used to evaluate the complexity of coronary lesions
before. mACEF score?s potential as a diagnostic tool needs to be evaluated to help
stratify patients eligible for coronary angiography.
Aim: To evaluate mACEF score?s diagnostic value and cut-off point as a
predictor of coronary lesion complexity in patients with CKD stages 3 and 4 with
ACS.
Methods: This study is a diagnostic test conducted retrospectively involving 179
subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012
to 2014. Cut-off analysis was performed using ROC curve with confidence
intervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed to
generate sensitivity, specificity, LR+, and LR-.
Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of
90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%.
Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively.;Background: Cardiovascular disease is one of the main causes of death mainly
due to delayed revascularization or complex coronary lesions which are usually
worse in CKD patients. Modified ACEF (mACEF) score is well established in
determining cardiovascular mortality of patients undergoing revascularization
therapy and has never been used to evaluate the complexity of coronary lesions
before. mACEF score?s potential as a diagnostic tool needs to be evaluated to help
stratify patients eligible for coronary angiography.
Aim: To evaluate mACEF score?s diagnostic value and cut-off point as a
predictor of coronary lesion complexity in patients with CKD stages 3 and 4 with
ACS.
Methods: This study is a diagnostic test conducted retrospectively involving 179
subjects with CKD stages 3 and 4 with ACS admitted to ICCU RSCM from 2012
to 2014. Cut-off analysis was performed using ROC curve with confidence
intervals (CI) of 95% and diagnostic accuracy of mACEF was analyzed to
generate sensitivity, specificity, LR+, and LR-.
Result: The optimal cut-off point for mACEF score was 2,288 with sensitivity of
90,9%, specificity 63,7%, LR+ 2,5, LR- 0,14, and prevalence of 55,3%.
Conclusion: mACEF score has a good diagnostic accuracy in subjects with CKD stage 3 and 4 with ACS with optimal cut-off point of 2,288, respectively."
Fakultas Kedokteran Universitas Indonesia, 2016
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Nababan, Saut Horas H
"ABSTRAK
Pendahuluan
Studi sebelumnya menunjukkan tebal adiposa epikardial pasien sindrom koroner akut (SKA) berhubungan dengan cardiovascular adverse event dalam tiga puluh hari.
Tujuan
Mengetahui peran tebal adiposa epikardial dalam memprediksi cardiovascular adverse event pada pasien SKA di ICCU RS Cipto Mangunkusumo.
Metode
Dilakukan studi kohort prospektif berbasis studi prognostik pada seratus dua puluh satu pasien SKA. Tebal adiposa epikardial dinilai dengan ekokardiografi transtorakal pada fase sistolik akhir (end-systole) tampilan parasternal long axis dari tiga siklus jantung. Dilakukan follow-up dalam tiga puluh hari pada semua pasien.
Hasil
Nilai median tebal adiposa epikardial adalah 2,23 mm (kisaran 0,37 – 10,8 mm). Cardiovascular adverse event terjadi pada 23 pasien (19%) dalam 30 hari; 9 subjek mengalami syok kardiogenik, 3 subjek mengalami infark miokard berulang, 4 subjek mengalami stroke iskemik, dan 7 subjek meninggal. Titik potong terbaik tebal adiposa epikardial dalam memprediksi cardiovascular adverse event adalah 2,95 mm dengan sensitivitas 65%, spesifisitas 70%, nilai duga positif 34%, nilai duga negatif 90% dengan AUC sebesar 0,690 (IK 95% 0,564-0,816, p=0,005).
Simpulan
Tebal adiposa epikardial 2,95 mm dapat digunakan untuk memprediksi cardiovascular adverse event dalam tiga puluh hari pada pasien SKA dengan sensitivitas 65%, spesifisitas 70% dan AUC 0,690.

ABSTRACT
Background
Previous study showed that epicardial adipose thickness in acute coronary syndrome (ACS) patients was associated with cardiovascular adverse events during thirty days.
Objective
To determine the role of epicardial adipose thickness in predicting cardiovascular adverse events in ACS patients at ICCU of Cipto Mangunkusumo Hospital
Method
A prospective cohort prognostic study was conducted on one hundred twenty-one ACS patients. Epicardial adipose thickness was measured with transthoracic echocardiography at end-systole from parasternal long-axis view of three cardiac cycles. 30 days follow-up was obtained in all patients.
Results
Median value of epicardial adipose thickness was 2.23 mm (range 0.37-10.8 mm). Cardiovascular adverse events were developed in 23 patients (19%) during 30 days; 9 cases of cardiogenic shock, 3 of recurrent myocardial infarction, 4 of ischemic stroke, and 7 of death. Best cut-off point of epicardial adipose thickness in predicting cardiovascular adverse events was 2.95 mm with a sensitivity of 65%, specificity 70%, positive predictive value 34%, negative predictive value 90% and AUC of 0.690 (95% CI 0.564 - 0.816, p = 0.005).
Conclusion
Epicardial adipose thickness with cut-off point 2.95 mm could be used to predict cardiovascular adverse events during thirty days in ACS patients with a sensitivity of 65%, specificity 70% and AUC of 0.690."
Fakultas Kedokteran Universitas Indonesia, 2012
T32758
UI - Tesis Membership  Universitas Indonesia Library
cover
Tasha Farhana Dahlan
"Latar Belakang
Sindrom koroner akut (SKA) masih merupakan salah satu penyebab mortalitas tertinggi di Indonesia. Data Riset Kesehatan Dasar (RISKESDAS) di Indonesia pada tahun 2018 menunjukkan prevalensi penyakit jantung pada penduduk semua umur sebesar 1,5%. Intervensi Koroner Perkutan (IKP) adalah salah satu Teknik revaskularisasi pada SKA. Meskipun dengan adanya IKP, luaran buruk, yaitu Major Adverse Cardiovascular Events (MACE) jangka pendek (30 hari) masih cukup tinggi.
Tujuan
Penelitian ini dilakukan untuk mengetahui prevalensi MACE 30 hari dan faktor prognostik kejadian MACE 30 hari pada pasien SKA yang menjalani IKP serta membuat model prediksinya.
Metode
Studi ini menggunakan desain kohort retrospektif dengan jumlah subjek sebesar 424 orang. Pemilihan subjek dilakukan secara konsekutif. Dilakukan analisis bivariat faktor risiko MACE 30 hari (Usia, Diabetes Mellitus, Hipertensi, Status Merokok, Penyakit Ginjal Kronik, Dislipidemia, Multiple Vessel Disease (MVD), Kadar asam urat darah, Fraksi Ejeksi Ventrikel Kiri, TIMI Flow grade, dan Rasio monosit-HDL) termasuk faktor risiko tambahan (Kelas Killip, Left Main Disease (LMD), kadar troponin, dan jenis SKA) lalu dilakukan analisis multivariat pada variabel yang bermakna.
Hasil
Didapatkan MACE 30 hari pada 54 subjek (12,74%). Pada analisis bivariat variabel yang bermakna adalah usia, fraksi ejeksi di bawah 40%, adanya LMD, MVD, peningkatan kelas Killip, dan peningkatan troponin. Model akhir yang didapatkan hanya meliputi kelas Killip dan fraksi ejeksi di bawah 40% dengan AUC 0,774.
Kesimpulan
Prevalensi MACE 30 hari pada pasien SKA paska IKP didapatkan 12,74%. Kelas Killip dan EF di bawah 40% dapat memprediksi kejadian MACE 30 hari pada pasien SKA paska IKP.

Background
Acute coronary syndrome (ACS) is still one of the highest causes of mortality in Indonesia. Basic Health Research Data (RISKESDAS) in 2018 showed that the prevalence of heart disease in the population of all ages was 1.5%. Percutaneous Coronary Intervention is one of the revascularization techniques in ACS. Despite the existence of Primary Coronary Intervention (PCI), adverse outcomes, collectively known as Major Adverse Cardiovascular Events (MACE) of 30 days are still quite high.
Objective
To determine the prevalence of 30 days MACE and prognostic factors and prediction model for the incidence of 30-day MACE in ACS patients undergoing PCI.
Method
This is a retrospective cohort study with a total of 424 subjects. Subject selection was carried out consecutively. A bivariate analysis of 30-day MACE risk factors (Age, Diabetes Mellitus, Hypertension, Smoking, Chronic Kidney Disease, Dyslipidemia, Multiple Vessel Disease (MVD), Uric Acid, Left Ventricle Ejection Fraction, TIMI Flow grade, and Monocyte-HDL ratio) including additional risk factors (Killip class, Left Main Disease (LMD), Troponin, and ACS type) was carried out and then a multivariate analysis was carried out on significant variables.
Results
Thirty-day MACE was found in 54 subjects (12.74%). In the bivariate analysis the significant variables were age, ejection fraction below 40%, presence of LMD, MVD, increased Killip class, and increased troponin. The final model obtained only includes the Killip class and an ejection fraction below 40% with an AUC of 0.774.
Conclusion
Prevalence of 30 days MACE I post PCI procedure patients were 12,74%. Killip class and EF below 40% can predict 30-day MACE events in ACS patients post PCI procedure.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2024
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Astuti Giantini
"Sindrom koroner akut (SKA) merupakan masalah kesehatan nasional karena tingginya angka morbiditas dan mortalitas serta beban biaya yang dibutuhkan. Intervensi koroner perkutan (IKP) dan terapi antiplatelet seperti klopidogrel merupakan tata laksana yang direkomendasikan oleh organisasi kardiologi internasional. Meskipun demikian, pasien SKA masih dapat mengalami kejadian kardiovaskular mayor (KKM). Kemungkinan, resistensi klopidogrel berperan pada KKM sedangkan resistensi klopidogrel mungkin dipengaruhi oleh faktor genetik dan epigenetik. Penelitian ini bertujuan untuk mengetahui hubungan faktor genetik yaitu polimorfisme gen CYP2C19 dan P2Y12, serta epigenetik yaitu metilasi DNA gen CYP2C19 dan P2Y12 serta ekspresi miRNA-26a dengan resistensi klopidogrel dan pengaruhnya terhadap KKM pada pasien SKA pasca IKP.
Untuk menganalisis hubungan faktor genetik dan epigenetik dengan resistensi klopidogrel, penelitian dilakukan dengan desain potong lintang, sedangkan untuk analisis hubungan faktor genetik dan epigenetik dengan KKM dilakukan dengan desain kohort prospektif. Subjek penelitian meliputi 201 pasien SKA pasca IKP dan mendapat terapi klopidogrel di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita dari bulan September 2018 sampai dengan Juni 2020. Resistensi klopidogrel ditentukan dengan pemeriksaan light transmission aggregometry (LTA) apabila hasilnya lebih besar dari 59% dengan agonis ADP 20 mM. Deteksi polimorfisme gen CYP2C19 dan P2Y12 serta ekspresi miRNA-26a dilakukan dengan metode qRT-PCR, sedangkan metilasi DNA gen CYP2C19 dan P2Y12 dikerjakan dengan metode konversi bisulfit. Pasien diobservasi selama satu tahun dan jika ada angina pektoris, infark miokard akut (IMA) rekuren, stroke, atau kematian, dicatat sebagai KKM.
Dari 201 subjek, terdapat 45,8% carrier mutant polimorfisme *2 dan *3 gen CYP2C19, 36,8% carrier mutant polimorfisme rs3679479 gen P2Y12, 10% hipometilasi DNA gen P2Y12, 80,1% hipometilasi DNA gen CYP2C19, dan 66,2% ekspresi miRNA-26a up regulated. Proporsi resisten klopidogrel adalah 49,8% dan proporsi KKM adalah 14,9% (kematian 7,5%). Terdapat hubungan antara merokok (p = 0,001; OR 0,37 [IK 95%; 0,20–0,68]), hipometilasi DNA gen CYP2C19 (p = 0,037; OR 2,13 [IK 95%; 1,04–4,37]), dan ekspresi miRNA-26a up regulated (p = 0,020; OR 2,03 [IK 95%; 1,12–3,68]) dengan resistensi klopidogrel. Terdapat hubungan antara jenis kelamin perempuan (p = 0,040; HR 2,73 [IK 95%; 1,05–7,14]), usia ≥ 60 tahun (p = 0,035; HR 2,17 [IK 95%; 1,06–4,48]), eGFR rendah (p = 0,001; HR 3,29 [IK 95%; 1,59–6,84]), dan polimorfisme *2 dan *3 gen CYP2C19 (p = 0,047; HR 2,12 [IK 95%; 1,01–4,46]) dengan KKM dalam satu tahun.
Hanya faktor epigenetik berupa metilasi DNA gen CYP2C19 dan ekspresi miRNA-26a yang berhubungan dengan resistensi klopidogrel. Walaupun resistensi klopidogrel tidak berhubungan dengan KKM, terdapat hubungan antara faktor genetik polimorfisme *2 dan *3 gen CYP2C19 dengan KKM.

Acute coronary syndrome (ACS) is a national health problem due to high morbidity and mortality, and cost burden as well. Percutaneous coronary intervention (PCI) and antiplatelet therapy such as clopidogrel are recommended. However, ACS patients could still experience major adverse cardiovascular events (MACE). Clopidogrel resistance possibly plays a role in MACE whereas it may be affected by genetic and epigenetic factors. Therefore, the objective of this study was to determine the relationship between genetic factors which are CYP2C19 and P2Y12 polymorphisms, as well as epigenetic factors which are DNA methylation of CYP2C19 and P2Y12, and miRNA-26a expression and their effects on MACE in post-PCI patients.
To analyze the association between genetic and epigenetic factors and clopidogrel resistance, the study design was cross-sectional, while the study design of relationship between genetic and epigenetic factors and MACE was prospective cohort. The subjects were 201 post-PCI ACS patients who received clopidogrel therapy at Harapan Kita Hospital from September 2018 to June 2020. Clopidogrel resistance was determined by light transmission aggregometry (LTA) if the result was greater than 59% with agonist ADP 20 µM. The detection of CYP2C19 and P2Y12 gene polymorphisms and miRNA-26a expression were carried out by qRT-PCR method, while the DNA methylation of the CYP2C19 and P2Y12 genes were carried out by bisulfite conversion method. Patients were observed for one year and angina pectoris, recurrent acute myocardial infarction (AMI), stroke, or death, were recorded as MACE.
From 201 subjects, 45.8% were CYP2C19*2 and CYP2C19*3 polymorphism mutant carrier, 36.8% were rs3679479 P2Y12 polymorphism mutant carrier, 10% were hypomethylated of P2Y12, 80.1% were hypomethylated of CYP2C19, and 66.2% were up regulated in miRNA-26a expression. 49.8% of subjects were clopidogrel resistant and 14.9% of subjects experienced MACE (death was 7.5%). Smoking (p = 0.001; OR 0.37 [CI 95%; 0.20–0.68]), hypomethylated of CYP2C19 (p = 0.037; OR 2.13 [CI 95%; 1.04–4.37]), and up regulated miRNA-26a expression (p = 0.020; OR 2.03 [CI 95%; 1.12–3.68]) were associated with clopidogrel resistance. Female gender (p = 0.040; HR 2.73 [CI 95%; 1.05–7.14]), age over 60 years old (p = 0.035; HR 2.17 [CI 95%; 1.06–4.48]), low eGFR (p = 0.001; HR 3.29 [CI 95%; 1.59–6.84]), and CYP2C19*2 and CYP2C19*3 polymorphisms (p = 0.047; HR 2.12 [CI 95%; 1.01–4.46]) were associated with MACE in one year.
Only DNA methylation of CYP2C19 and miRNA-26a expression were associated with clopidogrel resistance. Although clopidogrel resistance was not associated with MACE, there was association between CYP2C19*2 and CYP2C19*3 polymorphisms and MACE.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2021
D-Pdf
UI - Disertasi Membership  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>